60 Biggest Movers From Yesterday

Loading...
Loading...

Gainers

  • Tetraphase Pharmaceuticals, Inc. TTPH shares climbed 50% to close at $3.60 on Thursday.
  • Phathom Pharmaceuticals, Inc. PHAT gained 47.2% to close at $37.67.
  • Verona Pharma plc VRNA gained 44.9% to close at $6.58.
  • Liquidia Technologies, Inc. LQDA shares surged 43.5% to close at $5.05 on Thursday after Wedbush maintained an Outperform rating on the stock.
  • Acorda Therapeutics, Inc. ACOR shares gained 43.2% to close at $2.75.
  • NewLink Genetics Corporation NLNK rose 34.3% to close at $3.13 on above-average price action. The company announced an exclusive worldwide license with Ellipses Pharma on December 23rd.
  • Can-Fite BioPharma Ltd. CANF rose 30.5% to close at $3.89 after the company reported that strategic partnership with Univo to develop cannabinoid-based products is ongoing.
  • Acasti Pharma Inc. ACST gained 21.7% to close at $2.69 on a rebound after the stock price dropped on December 23rd after releasing news surrounding its TRILOGY 1 trial.
  • Mersana Therapeutics, Inc. MRSN rose 19.8% to close at $6.73.
  • Aprea Therapeutics, Inc. APRE gained 19.7% to close at $47.44.
  • Ruhnn Holding Limited RUHN rose 19.3% to close at $6.92.
  • Rite Aid Corporation RAD climbed 18.9% to close at $19.19.
  • DiaMedica Therapeutics Inc. DMAC rose 17.5% to close at $5.04.
  • Greenlane Holdings, Inc. GNLN rose 17.2% to close at $3.06.
  • McDermott International, Inc. MDR gained 17% to close at $1.24.
  • Atreca, Inc. BCEL surged 16.9% to close at $18.67.
  • Aldeyra Therapeutics, Inc. ALDX shares surged 16.6% to close at $6.62.
  • Oyster Point Pharma, Inc. OYST rose 16% to close at $26.15.
  • Indonesia Energy Corporation Limited INDO climbed 15.6% to close at $7.41.
  • Artelo Biosciences, Inc. ARTL rose 15.6% to close at $2.89.
  • Axcella Health Inc. AXLA surged 15.2% to close at $4.10.
  • Novan, Inc. NOVN shares gained 14.4% to close at $3.41.
  • SilverCrest Metals Inc. SILV rose 13.6% to close at $7.52.
  • Weidai Ltd. WEI gained 13.5% to close at $3.44.
  • Applied Therapeutics, Inc. APLT climbed 12.9% to close at $25.50.
  • Applied DNA Sciences, Inc. APDN surged 12.5% to close at $4.40.
  • Akerna Corp. KERN gained 11.6% to close at $8.79.
  • Grupo Supervielle S.A. SUPV jumped 11.5% to close at $4.18.
  • Nymox Pharmaceutical Corporation NYMX gained 11.1% to close at $2.40.
  • Clearside Biomedical, Inc. CLSD rose 11.1% to close at $3.40.
  • China Green Agriculture, Inc. CGA gained 10.8% to close at $2.80.
  • Anavex Life Sciences Corp. AVXL surged 10.3% to close at $2.79.
  • QuickLogic Corporation QUIK rose 9.1% to close at $4.43.
  • Technical Communications Corporation TCCO shares gained 8.9% to close at $5.13 after rising 10.3% on Tuesday.
  • Cellectar Biosciences, Inc. CLRB rose 8.5% to close at $2.43.
  • Proteostasis Therapeutics, Inc. PTI gained 8.4% to close at $2.44 after climbing 51.01% on Tuesday.
  • Equinox Gold Corp. EQX gained 7.6% to close at $7.68.
  • Synlogic, Inc. SYBX gained 7.1% to close at $2.57.
  • BioDelivery Sciences International, Inc. BDSI shares rose 7% to close at $7.06.
  • Soleno Therapeutics, Inc. SLNO surged 5.7% to close at $2.95.
  • Immunomedics, Inc. IMMU rose 5.7% to close at $21.67 after the company announced the FDA accepted for filing the company's BLA seeking accelerated approval of sacituzumab govitecan to treat metastatic triple-negative breast cancer.
  • SilverSun Technologies, Inc. SSNT shares rose 5.5% to close at $4.06.



Check out these big penny stock gainers and losers

Losers

  • Spring Bank Pharmaceuticals, Inc. SBPH shares dipped 66.8% to close at $1.20 on Thursday after the company reported that it has stopped dosing of inarigivir patients in Phase 2 program.
  • Spectrum Pharmaceuticals, Inc. SPPI shares tumbled 60% to close at $3.50 after the company reported that its pre-specified primary endpoint in the Phase 2 Trial of Poziotinib in the previously treated NSCLC was not met in the Cohort 1.
  • Hexo Corp HEXO dropped 21.9% to close at $1.53 after the company reported $25 million offering of 14.97 million shares at $1.67 per share.
  • QIAGEN N.V. QGEN fell 20.6% to close at $32.91 after the company announced it would not be acquired and it will stay a stand-alone business. Bank of America also reinstated its Underperform rating on the stock and announced a price target of $28 per share.
  • Microbot Medical Inc. MBOT fell 14% to close at $14.00 after climbing 61.03% on Tuesday. Microbot Medical, which recently unveiled a fully disposable robotic system for endovascular procedures, said it has entered into definitive agreements with certain institutional investors for the sale of 912,858 shares in a registered direct offering at a purchase price of $10.50, priced at-the-market under Nasdaq rules.
  • PhaseBio Pharmaceuticals, Inc. PHAS shares declined 13.4% to close at $6.36 after surging 12.3% on Tuesday.
  • RAPT Therapeutics, Inc. RAPT fell 13% to close at $26.77.
  • Recon Technology, Ltd. RCON dropped 12.9% to close at $0.5401
  • Stealth BioTherapeutics Corp MITO tumbled 11.9% to close at $3.56.
  • Cassava Sciences, Inc. SAVA fell 11.4% to close at $4.03 after surging 26.74% on Tuesday.
  • Harpoon Therapeutics, Inc. HARP fell 9.6% to close at $18.60.
  • Seadrill Limited SDRL shares declined 9.5% to close at $2.49.
  • Rubius Therapeutics, Inc. RUBY fell 8.8% to close at $11.81.
  • WW International, Inc. WW fell 8.6% to close at $37.32.
  • GoPro, Inc. GPRO shares declined 8.3% to close at $4.19.
  • Repro Med Systems, Inc. KRMD dropped 7% to close at $5.88.
  • TravelCenters of America Inc. TA dipped 6.2% to close at $17.64.
  • CLPS Incorporation CLPS dropped 5.3% to close at $6.06 after climbing 46.1% on Tuesday.
Loading...
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralHealth CareHuman Resource & Employment ServicesIndustrialsMovers From YesterdayPharmaceuticalsTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...